A, B., MW, A., & A, W. (2026). Optical coherence tomography biomarkers for neovascular age-related macular degeneration: Relevance for diagnosis, treatment, and prognosis. Die Ophthalmologie, 123(Suppl 2), 132. https://doi.org/10.1007/s00347-026-02445-5
Chicago Style (17th ed.) CitationA, Bindewald-Wittich, Alkabouni MW, and Wolf A. "Optical Coherence Tomography Biomarkers for Neovascular Age-related Macular Degeneration: Relevance for Diagnosis, Treatment, and Prognosis." Die Ophthalmologie 123, no. Suppl 2 (2026): 132. https://doi.org/10.1007/s00347-026-02445-5.
MLA (9th ed.) CitationA, Bindewald-Wittich, et al. "Optical Coherence Tomography Biomarkers for Neovascular Age-related Macular Degeneration: Relevance for Diagnosis, Treatment, and Prognosis." Die Ophthalmologie, vol. 123, no. Suppl 2, 2026, p. 132, https://doi.org/10.1007/s00347-026-02445-5.